NeXtGen Biologics, INC

CIK 1620524 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for NeXtGen Biologics, INC.

Recent SEC filings

FiledFormAccession number
Sep 22, 2025D0001620524-25-000007
Apr 29, 2024C-AR/A0001620524-24-000004
Apr 3, 2024C-AR0001620524-24-000001
Mar 10, 2023C-U0001796106-23-000001
Sep 2, 2022C0001620524-22-000002
Aug 17, 2020D0001620524-20-000001
Dec 27, 2018D0001415889-18-001836
May 24, 2017D/A0001620524-17-000001
Jun 16, 2016D0001620524-16-000002
Nov 23, 2015D0001620524-15-000001
Sep 24, 2014D0001620524-14-000001